Michael W. Parsons, PhD, ABPP, is a clinical neuropsychologist in the Pappas Neuro-Oncology Center and Department of Psychiatry at Massachusetts General Hospital. His clinical and research activities focus on the cognitive and behavioral consequences of cancer, including brain tumors and non-central nervous system cancers. He is the author of numerous peer reviewed manuscripts and book chapters related to these issues and serves as the copresident of the neuro-oncology special interest group of the International Neuropsychological Society. Dr. Parsons is a diplomate of the American Board of Clinical Neuropsychology and the American Board of Professional Psychology. Michelle M. Braun, PhD, ABPP, specializes in cognitive health, geriatric neuropsychology, and Alzheimer amp rsquo s risk reduction, and is passionate about sharing the science of brain health with the public through media, books, public education, and service innovation. Dr. Braun also has a special interest in neuropsychology advocacy. She completed her internship at Yale University School of Medicine, and her postdoctoral fellowship at Harvard Medical School/Boston VA after earning her doctoral degree in Clinical Psychology and minor in Neuroscience from the University of Wisconsin amp ndash Milwaukee. She is a former instructor of psychiatry at Harvard Medical School and assistant director of Inpatient Mental Health at the Boston Veterans amp rsquo Administration Hospital. Dr. Braun has been recognized as a Practitioner of the Year by the Alzheimer amp rsquo s Association, a 2 22 Woman of Influence by Success Magazine, a 2 22 Distinguished Alumna of Carroll University, and member of the amp ldquo 4 Under 4 amp rdquo class of 2 3 by the Milwaukee Business Journal. She has served as an examiner for the American Board of Clinical Neuropsychology since 2 5, member of the Board of Directors Scientific and Advisory Panel of the Wisconsin Alzheimer amp rsquo s Association since 2 , and previous board member of the Wisconsin Psychological Association and the American Academy of Clinical Neuropsychology, where she chaired the Practice and Public Policy Committee, and co-chaired its Legislative Subcommittee. Her bestselling book, High-Octane Brain: 5 Science-Based Steps to Sharpen Your Memory and Reduce Your Risk of Alzheimer amp rsquo s, empowers readers to optimize brain health and well-being with an inspiring personalized action plan and tracking system, and received a starred review from Library Journal.
This fourth edition of Clinical Neuropsychology continues a quarter century tradition of providing a comprehensive, state-of-the-art and science overview of clinical neuropsychology. Experienced and novice clinicians will find a wealth of information from leading scholars who address both classic and emerging neuropsychological syndromes including neuro-COVID and autoimmune conditions. The book also covers the latest technologies in our rapidly expanding field. -- Anthony Y. Stringer, PhD, ABPP/ABCN, Professor Emeritus, Division of Rehabilitation Neuropsychology, Emory University, Atlanta, GA This new edition of Clinical Neuropsychology not only has continued its time-honored tradition of providing a comprehensive account of the practice of clinical neuropsychology but has taken this to a new level. In addition to providing valuable professional updates and practical clinical takeaways in each chapter, it provides coverage of expanding roles and contributions of neuropsychologists in the healthcare arena. The book remains an invaluable resource for both the apprentice and seasoned clinician. -- Thomas A. Hammeke, PhD, ABPP/CN, Professor Emeritus, Psychiatry & Behavioral Medicine, Medical College of Wisconsin, Milwaukee, WI